Format
Sort by
Items per page

Send to

Choose Destination

Best matches for Ahnström J[au]:

Search results

Items: 34

1.

The transcription factor ERG regulates a low shear stress-induced anti-thrombotic pathway in the microvasculature.

Peghaire C, Dufton NP, Lang M, Salles-Crawley II, Ahnström J, Kalna V, Raimondi C, Pericleous C, Inuabasi L, Kiseleva R, Muzykantov VR, Mason JC, Birdsey GM, Randi AM.

Nat Commun. 2019 Nov 1;10(1):5014. doi: 10.1038/s41467-019-12897-w.

2.

The potential of serpins for future treatment for haemophilia.

Ahnström J.

J Thromb Haemost. 2019 Oct;17(10):1629-1631. doi: 10.1111/jth.14609. No abstract available.

PMID:
31571418
3.

Partial rescue of naturally occurring active site factor X variants through decreased inhibition by tissue factor pathway inhibitor and antithrombin.

Ahnström J, Gierula M, Temenu J, Laffan MA, Lane DA.

J Thromb Haemost. 2020 Jan;18(1):136-150. doi: 10.1111/jth.14627. Epub 2019 Sep 20.

PMID:
31466141
4.

The roles of factor Va and protein S in formation of the activated protein C/protein S/factor Va inactivation complex.

Gierula M, Salles-Crawley II, Santamaria S, Teraz-Orosz A, Crawley JTB, Lane DA, Ahnström J.

J Thromb Haemost. 2019 Dec;17(12):2056-2068. doi: 10.1111/jth.14594. Epub 2019 Aug 9.

5.

Exosites in Hypervariable Loops of ADAMTS Spacer Domains control Substrate Recognition and Proteolysis.

Santamaria S, Yamamoto K, Teraz-Orosz A, Koch C, Apte SS, de Groot R, Lane DA, Ahnström J.

Sci Rep. 2019 Jul 29;9(1):10914. doi: 10.1038/s41598-019-47494-w.

6.

Impact of lipoprotein apheresis on thrombotic parameters in patients with refractory angina and raised lipoprotein(a): Findings from a randomized controlled cross-over trial.

Khan TZ, Gorog DA, Arachchillage DJ, Ahnström J, Rhodes S, Donovan J, Banya W, Pottle A, Barbir M, Pennell DJ.

J Clin Lipidol. 2019 Sep - Oct;13(5):788-796. doi: 10.1016/j.jacl.2019.06.009. Epub 2019 Jul 2.

PMID:
31353231
7.

Defective fibrin deposition and thrombus stability in Bambi-/- mice are mediated by elevated anticoagulant function.

Crawley JTB, Zalli A, Monkman JH, Petri A, Lane DA, Ahnstrom J, Salles-Crawley II.

J Thromb Haemost. 2019 Nov;17(11):1935-1949. doi: 10.1111/jth.14593. Epub 2019 Aug 26.

8.

Biphasic activation of complement and fibrinolysis during the human nasal allergic response.

Thwaites RS, Gunawardana NC, Broich V, Mann EH, Ahnström J, Campbell GA, Lindsley S, Singh N, Tunstall T, Lane DA, Openshaw PJ, Hawrylowicz CM, Hansel TT.

J Allergy Clin Immunol. 2018 May;141(5):1892-1895.e6. doi: 10.1016/j.jaci.2018.01.022. Epub 2018 Feb 7. No abstract available.

9.

Factor V has an anticoagulant cofactor activity that targets the early phase of coagulation.

Santamaria S, Reglińska-Matveyev N, Gierula M, Camire RM, Crawley JTB, Lane DA, Ahnström J.

J Biol Chem. 2017 Jun 2;292(22):9335-9344. doi: 10.1074/jbc.M116.769570. Epub 2017 Apr 18.

10.

A low balance between microparticles expressing tissue factor pathway inhibitor and tissue factor is associated with thrombosis in Behçet's Syndrome.

Khan E, Ambrose NL, Ahnström J, Kiprianos AP, Stanford MR, Eleftheriou D, Brogan PA, Mason JC, Johns M, Laffan MA, Haskard DO.

Sci Rep. 2016 Dec 7;6:38104. doi: 10.1038/srep38104.

11.

Mycolactone-Dependent Depletion of Endothelial Cell Thrombomodulin Is Strongly Associated with Fibrin Deposition in Buruli Ulcer Lesions.

Ogbechi J, Ruf MT, Hall BS, Bodman-Smith K, Vogel M, Wu HL, Stainer A, Esmon CT, Ahnström J, Pluschke G, Simmonds RE.

PLoS Pathog. 2015 Jul 16;11(7):e1005011. doi: 10.1371/journal.ppat.1005011. eCollection 2015 Jul.

12.

Amino acid residues in the laminin G domains of protein S involved in tissue factor pathway inhibitor interaction.

Somajo S, Ahnström J, Fernandez-Recio J, Gierula M, Villoutreix BO, Dahlbäck B.

Thromb Haemost. 2015 May;113(5):976-87. doi: 10.1160/TH14-09-0803. Epub 2015 Feb 26.

PMID:
25716664
13.

Land-use intensity and the effects of organic farming on biodiversity: a hierarchical meta-analysis.

Tuck SL, Winqvist C, Mota F, Ahnström J, Turnbull LA, Bengtsson J.

J Appl Ecol. 2014 Jun;51(3):746-755. Epub 2014 Feb 7.

14.

TFPI cofactor function of protein S: essential role of the protein S SHBG-like domain.

Reglińska-Matveyev N, Andersson HM, Rezende SM, Dahlbäck B, Crawley JT, Lane DA, Ahnström J.

Blood. 2014 Jun 19;123(25):3979-87. doi: 10.1182/blood-2014-01-551812. Epub 2014 Apr 16.

15.

Vessel wall BAMBI contributes to hemostasis and thrombus stability.

Salles-Crawley II, Monkman JH, Ahnström J, Lane DA, Crawley JT.

Blood. 2014 May 1;123(18):2873-81. doi: 10.1182/blood-2013-10-534024. Epub 2014 Mar 13.

16.

Identification of functionally important residues in TFPI Kunitz domain 3 required for the enhancement of its activity by protein S.

Ahnström J, Andersson HM, Hockey V, Meng Y, McKinnon TA, Hamuro T, Crawley JT, Lane DA.

Blood. 2012 Dec 13;120(25):5059-62. doi: 10.1182/blood-2012-05-432005. Epub 2012 Oct 16.

PMID:
23074276
17.

Effects of organic farming on biodiversity and ecosystem services: taking landscape complexity into account.

Winqvist C, Ahnström J, Bengtsson J.

Ann N Y Acad Sci. 2012 Feb;1249:191-203. doi: 10.1111/j.1749-6632.2011.06413.x. Epub 2012 Feb 15. Review.

PMID:
22335471
18.

Apolipoprotein M binds oxidized phospholipids and increases the antioxidant effect of HDL.

Elsøe S, Ahnström J, Christoffersen C, Hoofnagle AN, Plomgaard P, Heinecke JW, Binder CJ, Björkbacka H, Dahlbäck B, Nielsen LB.

Atherosclerosis. 2012 Mar;221(1):91-7. doi: 10.1016/j.atherosclerosis.2011.11.031. Epub 2011 Nov 27.

PMID:
22204862
19.

Endothelium-protective sphingosine-1-phosphate provided by HDL-associated apolipoprotein M.

Christoffersen C, Obinata H, Kumaraswamy SB, Galvani S, Ahnström J, Sevvana M, Egerer-Sieber C, Muller YA, Hla T, Nielsen LB, Dahlbäck B.

Proc Natl Acad Sci U S A. 2011 Jun 7;108(23):9613-8. doi: 10.1073/pnas.1103187108. Epub 2011 May 23.

20.

Activated protein C cofactor function of protein S: a novel role for a γ-carboxyglutamic acid residue.

Ahnström J, Andersson HM, Canis K, Norstrøm E, Yu Y, Dahlbäck B, Panico M, Morris HR, Crawley JT, Lane DA.

Blood. 2011 Jun 16;117(24):6685-93. doi: 10.1182/blood-2010-11-317099. Epub 2011 Apr 20.

PMID:
21508412
21.

Mouse ApoM displays an unprecedented seven-stranded lipocalin fold: folding decoy or alternative native fold?

Sevvana M, Kassler K, Ahnström J, Weiler S, Dahlbäck B, Sticht H, Muller YA.

J Mol Biol. 2010 Dec 3;404(3):363-71. doi: 10.1016/j.jmb.2010.09.062. Epub 2010 Oct 7.

PMID:
20932978
22.

Plasma apolipoprotein M responses to statin and fibrate administration in type 2 diabetes mellitus.

Kappelle PJ, Ahnström J, Dikkeschei BD, de Vries R, Sluiter WJ, Wolffenbuttel BH, van Tol A, Nielsen LB, Dahlbäck B, Dullaart RP.

Atherosclerosis. 2010 Nov;213(1):247-50. doi: 10.1016/j.atherosclerosis.2010.07.048. Epub 2010 Aug 10.

PMID:
20828695
23.

Plasma levels of apolipoprotein M in normal and complicated pregnancy.

Ahnström J, Lindqvist PG, Walle U, Dahlbäck B.

Acta Obstet Gynecol Scand. 2010 Sep;89(9):1214-7. doi: 10.3109/00016349.2010.486434.

PMID:
20804348
24.

HDL stimulates apoM secretion.

Ahnström J, Axler O, Dahlbäck B.

Protein Pept Lett. 2010 Oct;17(10):1285-9.

PMID:
20518736
25.

Plasma concentrations of apolipoproteins A-I, B, and M in patients with critical limb ischemia.

Ahnström J, Gottsäter A, Lindblad B, Dahlbäck B.

Clin Biochem. 2010 Apr;43(6):599-603. doi: 10.1016/j.clinbiochem.2010.01.001. Epub 2010 Jan 18.

PMID:
20080084
26.

Plasma concentrations of apolipoproteins A-I, B and M in patients with abdominal aortic aneurysms.

Ahnström J, Gottsäter A, Lindblad B, Dahlbäck B.

Clin Biochem. 2010 Mar;43(4-5):407-10. doi: 10.1016/j.clinbiochem.2009.11.006. Epub 2009 Nov 22.

PMID:
19932694
27.

Serendipitous fatty acid binding reveals the structural determinants for ligand recognition in apolipoprotein M.

Sevvana M, Ahnström J, Egerer-Sieber C, Lange HA, Dahlbäck B, Muller YA.

J Mol Biol. 2009 Nov 6;393(4):920-36. doi: 10.1016/j.jmb.2009.08.071. Epub 2009 Sep 4.

PMID:
19733574
28.

ApoM: gene regulation and effects on HDL metabolism.

Nielsen LB, Christoffersen C, Ahnström J, Dahlbäck B.

Trends Endocrinol Metab. 2009 Mar;20(2):66-71. doi: 10.1016/j.tem.2008.11.003. Epub 2009 Feb 4.

PMID:
19200746
29.

Levels of apolipoprotein M are not associated with the risk of coronary heart disease in two independent case-control studies.

Ahnström J, Axler O, Jauhiainen M, Salomaa V, Havulinna AS, Ehnholm C, Frikke-Schmidt R, Tybjaerg-Hansen A, Dahlbäck B.

J Lipid Res. 2008 Sep;49(9):1912-7. doi: 10.1194/jlr.M700471-JLR200. Epub 2008 May 19.

30.

The signal peptide anchors apolipoprotein M in plasma lipoproteins and prevents rapid clearance of apolipoprotein M from plasma.

Christoffersen C, Ahnström J, Axler O, Christensen EI, Dahlbäck B, Nielsen LB.

J Biol Chem. 2008 Jul 4;283(27):18765-72. doi: 10.1074/jbc.M800695200. Epub 2008 May 5.

31.

Apolipoprotein M associates to lipoproteins through its retained signal peptide.

Axler O, Ahnström J, Dahlbäck B.

FEBS Lett. 2008 Mar 5;582(5):826-8. doi: 10.1016/j.febslet.2008.02.007. Epub 2008 Feb 13.

32.

An ELISA for apolipoprotein M reveals a strong correlation to total cholesterol in human plasma.

Axler O, Ahnström J, Dahlbäck B.

J Lipid Res. 2007 Aug;48(8):1772-80. Epub 2007 May 25.

33.

Hydrophobic ligand binding properties of the human lipocalin apolipoprotein M.

Ahnström J, Faber K, Axler O, Dahlbäck B.

J Lipid Res. 2007 Aug;48(8):1754-62. Epub 2007 May 24. Erratum in: J Lipid Res. 2010 Jul;51(7):2012.

34.

Supplemental Content

Loading ...
Support Center